[Management of ascites in cirrhotic patients]

Nihon Shokakibyo Gakkai Zasshi. 2017;114(1):27-34. doi: 10.11405/nisshoshi.114.27.

[Article in Japanese]

Authors

Masayuki Kurosaki¹, Hiroyuki Nakanishi, Namiki Izumi

Affiliation

¹ Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital.

PMID: 28070092
DOI: 10.11405/nisshoshi.114.27

No abstract available

Publication types

Review

MeSH terms

Antidiuretic Hormone Receptor Antagonists / administration & dosage
Antidiuretic Hormone Receptor Antagonists / pharmacology
Antidiuretic Hormone Receptor Antagonists / therapeutic use*
Aquaporin 2 / metabolism
Ascites / etiology*
Ascites / therapy*
Benzazepines / administration & dosage
Benzazepines / pharmacology
Benzazepines / therapeutic use*
Diuretics / administration & dosage
Diuretics / therapeutic use
Humans
Japan
Liver Cirrhosis / complications*
Practice Guidelines as Topic
Receptors, Vasopressin / metabolism
Signal Transduction / drug effects
Sodium Potassium Chloride Symporter Inhibitors / administration & dosage
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
Spironolactone / administration & dosage
Spironolactone / therapeutic use
Tolvaptan
Vasopressins

Substances

Antidiuretic Hormone Receptor Antagonists
Aquaporin 2
Benzazepines
Diuretics
Receptors, Vasopressin
Sodium Potassium Chloride Symporter Inhibitors
Vasopressins
Tolvaptan
Spironolactone